1 03, 2025 Veronica Agostinelli et al., The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy adlitterio663392025-03-07T15:14:35+01:00 Leggi di più
18 02, 2025 HAL?M ÖZÇEV?K ET AL., Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective adlitterio663392025-03-07T15:24:15+01:00 Leggi di più
15 02, 2025 Robrto Montalti et al., Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study adlitterio663392025-03-07T15:21:16+01:00 Leggi di più
13 02, 2025 Seda Er Özilhan et al., Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer adlitterio663392025-03-07T15:16:52+01:00 Leggi di più
27 01, 2025 Elisabetta Maffei et al., Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers adlitterio663392025-03-07T15:10:22+01:00 Leggi di più
2 01, 2025 Jessica Lucchetti et al., Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort adlitterio663392025-03-07T14:45:59+01:00 Leggi di più
19 11, 2024 Rosanna Squitti et al., Copper dysmetabolism is connected to epithelial-mesenchymal transition: A pilot study in colorectal cancer patients adlitterio663392025-01-02T13:01:11+01:00 Leggi di più
15 11, 2024 Krishnamurthy Hari et al., Classification of colorectal cancer patients based on serum micronutrients: An exploratory investigation adlitterio663392025-01-02T13:02:14+01:00 Leggi di più
30 10, 2024 Laura Simone et al., Tailored treatment and clinical management for DPYD compound heterozygous: a multidisciplinary teamwork adlitterio663392025-01-02T11:41:27+01:00 Leggi di più
28 10, 2024 Pasquale Pisapia et al., The relevance of the reference range for EGFR testing in non-small cell lung cancer patients adlitterio663392025-01-02T11:28:30+01:00 Leggi di più
